Start Your Risk-Free Trial

Semaglutide (Obesity) — Discount Pricing

Semaglutide (Obesity) is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.

Semaglutide (Obesity) Pricing

Pricing typePrice
TheDrugClubDiscount pricing may be available
Typical Retail$153.00

Discount pricing may be available; confirm the price with the dispensing pharmacy.

About Semaglutide (Obesity)

Semaglutide (Obesity) is a prescription medication. Ask your doctor if Semaglutide (Obesity) is right for you.

How to Check Semaglutide (Obesity) Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available discount pricing

Semaglutide (Obesity) at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Other medications in Diabetes & Metabolism

About Semaglutide (Obesity)

Semaglutide has emerged as a significant medication in the fight against obesity, offering a new pathway for many struggling with weight management. At TheDrugClub, we understand the importance of affordable healthcare. Our members can explore potential savings on semaglutide prescriptions, helping to make this vital treatment more accessible.

Semaglutide, often recognized by its brand names, is a prescription medication approved for chronic weight management in adults. It's typically prescribed as an adjunct to a reduced-calorie diet and increased physical activity. This medication is indicated for individuals with a Body Mass Index (BMI) of 27 kg/m² or greater who also have at least one weight-related comorbid condition (such as high blood pressure, type 2 diabetes, or high cholesterol), or for those with a BMI of 30 kg/m² or greater (classified as obese). It serves as a powerful tool to help patients achieve and maintain significant weight loss.

How Semaglutide Works for Weight Management

Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists. It mimics the action of glucagon-like peptide-1 (GLP-1), a natural hormone produced in the gut that plays a crucial role in appetite regulation and glucose metabolism. When administered, semaglutide activates GLP-1 receptors in the brain, which leads to a reduction in appetite and an increase in feelings of fullness (satiety). Additionally, it

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Semaglutide (Obesity) is approved for (FDA label)

OZEMPIC is indicated: • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. • to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease. • to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes mellitus and chronic kidney disease.

Source: Read the full FDA label on DailyMed. Label effective date: July 30, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial